ING Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.71M | Sell |
45,160
-151,468
| -77% | -$20M | 0.03% | 304 |
|
|
2026
Q1 | $27.4M | Sell |
196,628
-167,726
| -46% | -$23.5M | 0.17% | 105 |
|
|
2025
Q4 | $44.7M | Buy |
364,354
+177,642
| +95% | +$21.6M | 0.27% | 73 |
|
|
2025
Q3 | $20.7M | Sell |
186,712
-100,856
| -35% | -$11.5M | 0.11% | 124 |
|
|
2025
Q2 | $31.9M | Sell |
287,568
-27,460
| -9% | -$2.92M | 0.19% | 81 |
|
|
2025
Q1 | $35.3M | Buy |
315,028
+55,645
| +21% | +$5.74M | 0.24% | 72 |
|
|
2024
Q4 | $24M | Sell |
259,383
-133,302
| -34% | -$12M | 0.16% | 103 |
|
|
2024
Q3 | $32.9M | Buy |
392,685
+109,788
| +39% | +$8.38M | 0.19% | 89 |
|
|
2024
Q2 | $19.4M | Sell |
282,897
-19,031
| -6% | -$1.27M | 0.12% | 136 |
|
|
2024
Q1 | $22.1M | Sell |
301,928
-630,040
| -68% | -$48.4M | 0.15% | 120 |
|
|
2023
Q4 | $75.5M | Buy |
931,968
+457,847
| +97% | +$35.6M | 0.61% | 28 |
|
|
2023
Q3 | $35.5M | Sell |
474,121
-300,791
| -39% | -$23.1M | 0.31% | 69 |
|
|
2023
Q2 | $59.7M | Buy |
774,912
+534,194
| +222% | +$42.6M | 0.45% | 45 |
|
|
2023
Q1 | $20M | Sell |
240,718
-94,714
| -28% | -$7.84M | 0.19% | 100 |
|
|
2022
Q4 | $28.8M | Buy |
335,432
+46,694
| +16% | +$3.7M | 0.29% | 71 |
|
|
2022
Q3 | $17.8M | Sell |
288,738
-27,709
| -9% | -$1.75M | 0.3% | 72 |
|
|
2022
Q2 | $19.6M | Buy |
316,447
+36,811
| +13% | +$2.28M | 0.23% | 81 |
|
|
2022
Q1 | $16.6M | Buy |
279,636
+54,889
| +24% | +$3.51M | 0.17% | 103 |
|
|
2021
Q4 | $16.3M | Buy |
224,747
+91,288
| +68% | +$6.29M | 0.15% | 128 |
|
|
2021
Q3 | $9.32M | Buy |
133,459
+2,748
| +2% | +$193K | 0.12% | 126 |
|
|
2021
Q2 | $9M | Buy |
130,711
+41,923
| +47% | +$2.8M | 0.14% | 107 |
|
|
2021
Q1 | $5.74M | Buy |
88,788
+3,643
| +4% | +$235K | 0.12% | 113 |
|
|
2020
Q4 | $4.96M | Buy |
85,145
+55,398
| +186% | +$3.34M | 0.11% | 124 |
|
|
2020
Q3 | $1.88M | Buy |
29,747
+16,488
| +124% | +$1.14M | 0.08% | 133 |
|
|
2020
Q2 | $1.02M | Sell |
13,259
-130,973
| -91% | -$10M | 0.04% | 123 |
|
|
2020
Q1 | $10.8M | Buy |
144,232
+58,773
| +69% | +$4.06M | 0.46% | 37 |
|
|
2019
Q4 | $5.55M | Buy |
85,459
+6,423
| +8% | +$418K | 0.17% | 102 |
|
|
2019
Q3 | $5.01M | Sell |
79,036
-299,719
| -79% | -$19.6M | 0.13% | 122 |
|
|
2019
Q2 | $25.6M | Buy |
378,755
+297
| +0.1% | +$19.5K | 0.45% | 45 |
|
|
2019
Q1 | $24.6M | Buy |
378,458
+39,568
| +12% | +$2.63M | 0.53% | 33 |
|
|
2018
Q4 | $21.2M | Buy |
338,890
+3,456
| +1% | +$242K | 0.46% | 47 |
|
|
2018
Q3 | $25.9M | Buy |
335,434
+12,700
| +4% | +$959K | 0.45% | 48 |
|
|
2018
Q2 | $22.9M | Buy |
322,734
+236,424
| +274% | +$16.7M | 0.44% | 41 |
|
|
2018
Q1 | $6.51M | Buy |
86,310
+82,008
| +1,906% | +$6.52M | 0.12% | 105 |
|
|
2017
Q4 | $308K | Sell |
4,302
-470,389
| -99% | -$35.7M | 0.01% | 637 |
|
|
2017
Q3 | $38.5M | Buy |
474,691
+37,698
| +9% | +$2.88M | 0.74% | 33 |
|
|
2017
Q2 | $30.9M | Sell |
436,993
-15,789
| -3% | -$1.05M | 0.59% | 30 |
|
|
2017
Q1 | $30.8M | Buy |
452,782
+80,061
| +21% | +$5.63M | 0.56% | 38 |
|
|
2016
Q4 | $26.9M | Sell |
372,721
-35,169
| -9% | -$2.61M | 0.5% | 39 |
|
|
2016
Q3 | $31.8M | Buy |
407,890
+275,666
| +208% | +$22.4M | 0.38% | 47 |
|
|
2016
Q2 | $11M | Sell |
132,224
-748,634
| -85% | -$66.4M | 0.15% | 81 |
|
|
2016
Q1 | $80.7M | Sell |
880,858
-1,892,412
| -68% | -$171M | 1.01% | 21 |
|
|
2015
Q4 | $281M | Buy |
2,773,270
+978,546
| +55% | +$102M | 1.69% | 6 |
|
|
2015
Q3 | $176M | Buy |
1,794,724
+216,203
| +14% | +$24M | 1.22% | 13 |
|
|
2015
Q2 | $185M | Buy |
1,578,521
+183,994
| +13% | +$20.1M | 1% | 17 |
|
|
2015
Q1 | $137M | Sell |
1,394,527
-55,543
| -4% | -$5.64M | 0.69% | 27 |
|
|
2014
Q4 | $137M | Buy |
1,450,070
+356,778
| +33% | +$36.9M | 0.64% | 29 |
|
|
2014
Q3 | $116M | Buy |
1,093,292
+450,825
| +70% | +$44.1M | 0.68% | 29 |
|
|
2014
Q2 | $53.3M | Buy |
642,467
+292,087
| +83% | +$22.7M | 0.27% | 81 |
|
|
2014
Q1 | $24.8M | Buy |
350,380
+240,958
| +220% | +$18.9M | 0.13% | 169 |
|
|
2013
Q4 | $8.22M | Buy |
109,422
+87,265
| +394% | +$6.08M | 0.04% | 310 |
|
|
2013
Q3 | $1.39M | Buy |
22,157
+6,707
| +43% | +$401K | 0.01% | 530 |
|
|
2013
Q2 | $791K | Buy |
+15,450
| New | +$805K | ﹤0.01% | 562 |
|
Other funds holding GILD
ING Group's GILD Position: Q2 2026 in Review
ING Group reduced its Gilead Sciences (GILD) stake by 77% in Q2 2026, selling an estimated $20M and leaving 45,160 shares worth $5.71M. The position accounts for 0.03% of the portfolio, ranked #304.
ING Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $281M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- ING Group held 45,160 shares of Gilead Sciences worth $5.71M as of Q2 2026.
- ING Group sold 151,468 Gilead Sciences shares in Q2 2026, an estimated $20M.
- Gilead Sciences made up 0.03% of ING Group's portfolio in Q2 2026, its #304 holding.
- ING Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- ING Group's Gilead Sciences position peaked at $281M in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.